Poolbeg Pharma Share Discussion Threads

[chica1] 09/10/2024 16:03

,
ok I'll just put him on ignore😁

[chica1] 09/10/2024 15:25

LFD I bet he spoke to Cathal Friel.
I'm still waiting for the Disease in Motion deal with Apple or was it Google or Fitbit or all 3.🙄...Poolbeg is no Inflazome!

By the way here comes the .

[pogue] 09/10/2024 15:23

Ta Ta I will add you to the filter list as you know nothing I need to know.

[lfdkmp] 09/10/2024 15:13

We clearly agree on something.

( for troll substitute opinionated, self absorbed prat)

Final direct comment to you,.. I have no desire to engage with a "researched", wide eyed, gazing with joy, communicant of POLB and HVO... probably a novice of the Cathal Friel academy.

[pogue] 09/10/2024 14:38

adorling
All AIM shares drift on no news currently. This went up on the 2 pharma's interest but its taking time to do the deal. It appears they did the animal trails first whether they will include the deal in the contract for the human trial as normal or wait till after we dont know. Either way hoops have to be jumped through and deals agreed. Pharma deals take a long time, always the same.

[lfdkmp] 09/10/2024 13:58

You and your "research" theme are becoming a bit.. erm ... tired.

[pogue] 09/10/2024 13:47

Waiting on the contract, you done any research? I am guessing not.

[lfdkmp] 09/10/2024 13:41

Has this "capital light, short runway, POLB 001" model got no clothes?

[pogue] 09/10/2024 13:07

Filtering doesnt make any difference that the reason I am putting the dots in. All those I filter keep appearing as new posts but on my phone it doesnt say who has made the new post so I have to go in to see now new post.
Anyone else who dislikes this report it as I have.
Nothing much happening here anyway. Its just waiting for news.
Edit
I notice you replying on the HVO thread to Sikh, thats worse than putting a '.' you are just keeping the trolls happy and replying to nonsense.

[supernumerary] 09/10/2024 12:39

That's twice I've come here to find it's only the same dot by pogue.

Sorry, pogue, but filtered.

[malcolmz1] 09/10/2024 12:27

People really don't like facing the reality of a share price that's 50% down.

[joseph moran] 07/10/2024 10:28

I can buy these at Last Quote

07/10/24

11:26:28
LSE

Open

£0.0859

sells are showing at this price?

[baldrick1] 04/10/2024 08:15

Once the cash runs out. I will only consider buying this at placing price if they opt for funding raise.

[melody9999] 20/9/2024 08:44

I wish some posters would stop making things personal. We all have different views.

Here IMV the investment thesis is predicated on you having enough conviction that Jeremy and the old Amryt team will be able to monetise any or all of the portfolio with big pharma.
If they do - happy days. But there is an opportunity cost of leaving your money here instead of investing elsewhere in a market that is cheap and .... once we get the Budget out of the way ....will IMV be rising again.

My money is elsewhere!

[pogue] 19/9/2024 21:05

1gw
They are pretty confident that changing the delivery of obesity drugs from injection to oral will be a game changer. Someone will come calling. The actual tests run over night volunteer come in one day take the pill come back next day. They can't do them all in one day thought so trial will take a month or so. Very easy to see if the tablet has gone into bloodstream.

[sikhthetech] 19/9/2024 19:33

Pogue

"investors now have lack of patience or lack of knowledge in the company."


Or investors got fed up with the fact that the company has NIL revenue, increasing costs and declining cash.

Obviously it can't be that. It must be a lack of patience or they haven't researched the company properly.

Treating investors like idiots just because they not piling in...


You making things up, like 1gw and his mates? lol

[1gw] 19/9/2024 18:51

chica1 - according to the interims:

"We are progressing towards the initiation of a proof-of-technology clinical trial in late 2024 to demonstrate the successful delivery of an oral GLP-1R agonist in humans."

How marketable that asset would be in the event of a "successful" trial remains to be seen.